Sign up to save your podcasts
Or
Share Does finding a rare mutation accomplish anything?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Does finding a rare mutation accomplish anything?
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
View all episodes
By Illumina, Inc.
4.7
6767 ratings
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
More shows like Illumina Genomics Podcast
View all
Science Friday
6,052 Listeners
Nature Podcast
761 Listeners
Science Magazine Podcast
809 Listeners
Planet Money
30,850 Listeners
This Week in Virology
2,053 Listeners
Freakonomics Radio
32,184 Listeners
Hidden Brain
43,251 Listeners
This Week in Virology
226 Listeners
The Long Run with Luke Timmerman
117 Listeners
The Indicator from Planet Money
9,531 Listeners
The Readout Loud
316 Listeners
The Peter Attia Drive
7,811 Listeners
Short Wave
6,223 Listeners
Dwarkesh Podcast
325 Listeners
Behind the Genes
4 Listeners